Company News

Stay up to date on the exciting events that happen with Tower MSA and our industry.

FDA Mandates New Warnings for Opioid and Benzodiazepines

Posted on September 20, 2016 by Rita Wilson

In a statement released on September 1, 2016 (FDA Black Box Warning), the Food and Drug Administration (FDA) announced that “after an extensive review of the latest scientific evidence, it is requiring class-wide changes to drug labeling, including patient information,…

Read more

FDA Approves Long-Lasting Narcotic – Oxycodone / Acetaminophen

Posted on March 19, 2014 by Rita Wilson

The first FDA approved long-acting combination of narcotic analgesic oxycodone with acetaminophen is now available for pain management. It will be manufactured by Mallinckrodt and is a single strength tablet to be dosed twice daily. This new form of pain…

Read more

Request to FDA to Change Opioid Labels

Posted on October 1, 2012 by Rita Wilson

To those who may not know, PROP (Physicians for Responsible Opioid Prescribing) http://www.supportprop.org/ is an organization comprised of practicing physicians whose mission is “to reduce morbidity and mortality resulting from prescribing of opioids, and to promote cautious, safe and responsible opioid prescribing practices.”  …

Read more

For Media Inquires, Contact:

Helen King Patterson
813.690.4787
helen@kingknight.com

    Subscribe to our blog & news

    Search our blog:

    Contact Us for a FREE Consultation